Review Article

Stem Cell-Based Cell Therapy for Glomerulonephritis

Table 2

Clinical trials of stem cell therapy in glomerulonephritis (GN).

Study/name of the trialStudy designNumber of patientsType of GNCell typeDelivery methodCell doseFollow-up periodOutcomesSide effects in cell-treated patientsReference number

Jayne et al. (2004)Nonrandomized, uncontrolled study53 (33 had nephritis)LNAutologous hematopoietic stem cell Vein infusion26 (0–78) monthsStabilization or improvement in renal function; no patients developed new renal involvementNo major complications reported[43]

Thirabanjasak et al. (2010)Case report1LNAutologous hematopoietic stem cellRenal injectionNo improvement in renal functionDevelopment of angiomyeloproliferative lesions at the sites of infection when 3 month after cell therapy[33]

El-Ansary et al.
(2012)
Nonrandomized, uncontrolled study10LNMesenchymal stem cellInfusion intravenously0.7–  cell/kg in two divided doses 1 week apart6 months↓Scr
↑creatinine clearance
No major complications reported[29]

Belingheri et al. (2013)Case report1FSGSHuman allogeneic bone marrow mesenchymal stem cellsVein infusion  cell/kg 22 monthsNormal and stable renal function (Scr↓, GFR↑)No major complications reported[44]

Su et al. (2013)Nonrandomized, uncontrolled study5 (kidney involved in 4)LNAutologous peripheral blood hematopoietic stem cellVein infusion40–83 monthsAll went into clinical remission in 3–6 months; two recurred at the end of follow-up periodNo major complications reported[45]

Alchi et al. (2013)Nonrandomized, uncontrolled study28 (17 had nephritis)LNHaematopoietic stem cell transplantationInfusion intravenously38 months↑improvement in renal functionNo major complications reported[46]

Rampino et al. (2011)Case report1Renal ANCA-associated vasculitisBone marrow mesenchymal stromal cellsInfusion intravenously  cell/kg12 monthsClinical remissionNo major complications reported[18]

LN—lupus nephritis.
FSGS—focal segmental glomerulosclerosis.